Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DLBS1033 for Hypercoagulation in Type 2 Diabetes
NCT01865474Phase 4Completed
- Sponsor
- Dexa Medica
- Start
- May 2013
- Primary completion
- Jun 2016
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of DLBS1033 in type 2 diabetes mellitus (T2DM), sponsored by Dexa Medica. Started May 2013; status: completed.
02
Drugs
DLBS1033
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01865474.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01865474.